Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 49, 2019 - Issue 3
277
Views
2
CrossRef citations to date
0
Altmetric
Articles

Exploratory applications of 2-nitrobenzaldehyde-derived Morita-Baylis-Hillman adducts as synthons in the construction of drug-like scaffolds

, &
Pages 417-430 | Received 21 May 2018, Accepted 10 Dec 2018, Published online: 14 Jan 2019

References

  • World Health Organization Report, 2012. https://ourworldindata.org/malaria/ (accessed March 22, 2017).
  • Hyde, J. E. Exploring the Folate Pathway in Plasmodium Falciparum. Acta Trop. 2005, 94,191-206. DOI: 10.1016/j.actatropica.2005.04.002.
  • Laurent, C.; Peeters, M.; Delaporte, E. HIV/AIDS Infections in the World with a Special Focus on Africa in Encyclopedia of Infectious Diseases, Modern Methodologies; Tibayrenc, M., Ed.; John Wiley & Sons Inc. Publication: NJ, USA, 2007; pp45-57.
  • Bodiwala, H. S.; Sabde, S.; Gupta, P.; Mukherjee, R.; Kumar, R.; Garg, P.; Bhutani, K. K.; Mitra, D.; Singh, I. P. Design and Synthesis of Caffeoyl-Anilides as Portmanteau Inhibitors of HIV-1 Integrase and CCR5. Bioorg. Med. Chem. 2011, 19,1256-1263. DOI: 10.1016/j.bmc.2010.12.031.
  • Wayengera, M. B. HIV & AIDS Rev. 2011, 10,1-8. DOI: 10.1016/j.hivar.2011.01.002.
  • Adeyemi, C. M.; Isaacs, M.; Mnkandhla, D.; Klein, R.; Hoppe, H. C.; Krause, R. W. M.; Lobb, K. A.; Kaye, P. T. Synthesis and anti-parasitic Activity of C -benzylated ( N -arylcarbamoyl)alkylphosphonate Esters. Tetrahedron 2017, 73,1661-1667. DOI: 10.1016/j.tet.2017.01.045.
  • Adeyemi, C. M.; Faridoon; Isaacs, M.; Mnkandhla, D.; Hoppe, H. C.; Krause, R. W. M.; Kaye, P. T. Bioorg. Med. Chem. 2016, 24,6131-6138. DOI: 10.1016/j.bmc.2016.04.021.
  • (a) Rohmer, M.; Seemann, M.; Horbach, S.; Bringer-Meyer, S.; Sahm, H. J. Am. Chem. Soc. 1996, 118,2564-2566. (b) Odom, A. R.; Van Voorhis, W. C. Mol. Biochem. Parasitol. 2010, 170,108-111. DOI: 10.1021/ja9538344.
  • Kaye, P. T.; Musa, M. A.; Nchinda, A. T.; Nocanda, X. W. Novel Heterocyclic Analogues of the HIV‐1 Protease Inhibitor, Ritonavir. Synth. Commun. 2004, 34,2575-2589. DOI: 10.1081/SCC-200025617.
  • Stuk, T. L.; Haight, A. R.; Scarpetti, D.; Allen, M. S.; Menzia, J. A.; Robbins, T. A.; Parekh, S. I.; Langridge, D. C.; Tien, J.-H. J.; Pariza, R. J.; et al. An Efficient Stereocontrolled Strategy for the Synthesis of Hydroxyethylene Dipeptide Isosteres. J. Org. Chem. 1994, 59,4040-4041. DOI: 10.1021/jo00094a006.
  • Olomola, T. O.; Klein, R.; Lobb, K. A.; Sayed, Y.; Kaye, P. T. Towards the Synthesis of Coumarin Derivatives as Potential Dual-Action HIV-1 Protease and Reverse Transcriptase Inhibitors. Tetrahedron Lett. 2010, 51,6325-6328. DOI: 10.1016/j.tetlet.2010.09.121.
  • De Clercq, E. Anti-HIV Drugs: 25 Compounds Approved within 25 Years after the Discovery of HIV. Int. J. Antimicrob. Agents 2009, 33,307-320. DOI: 10.1016/j.ijantimicag.2008.10.010.
  • Pommier, Y.; Johnson, A. A.; Marchand, C. Integrase Inhibitors to Treat HIV/AIDS. Nat. Rev. Drug Discov. 2005, 4,236-248. DOI: 10.1038/nrd1660.
  • Dayam, R.; Gundla, R.; Al-Mawsawi, L. Q.; Neamati, N. HIV-1 Integrase Inhibitors: 2005-2006 Update. Med. Res. Rev. 2008, 28,118-154. DOI: 10.1002/med.20116.
  • Lee, S. U.; Shin, C. G.; Lee, C. K.; Lee, Y. S. Caffeoylglycolic and Caffeoylamino Acid Derivatives, Halfmers of L-chicoric Acid, as New HIV-1 Integrase Inhibitors. Eur. J. Med. Chem. 2007, 42,1309-1315. DOI: 10.1016/j.ejmech.2007.02.016.
  • Familoni, O. B.; Klaas, P. J.; Lobb, K. A.; Pakade, V. E.; Kaye, P. T. The Baylis-Hillman Approach to Quinoline Derivatives. Org. Biomol. Chem. 2006, 4,3960-3965. DOI: 10.1039/B608592J.
  • Ahmad, A.; Dunbar, L. J.; Green, I. G.; Harvey, I. W.; Shepherd, T.; Smith, D. M.; Wong, R. K. C. Polyaza Heterocycles. Part 2. Nucleophilic Substitution of Halogens in Halogenoquinoxalino[2,3-c]Cinnolines. J. Chem. Soc., Perkin Trans. 1994, 1,2751-2758. DOI: 10.1039/P199400FX073.
  • Xiong, X. D.; Chen, W.; Kuang, Y. Y.; Chen, F. E. A Novel and Practical Synthesis of 2-Amino-5-Hydroxypropiophenone. Org. Prep. Proced. Int. 2009, 41,423-427. DOI: 10.1080/00304940903187615.
  • Familoni, B. O.; Kaye, P. T.; Klaas, P. Application of Baylis-Hillman Methodology in a Novel Synthesis of Quinoline Derivatives. Chem. Commun. 1998, 2563-2564. DOI: 10.1039/A804394I.
  • Sekgota, K. C.; Majumder, S.; Isaacs, M.; Mnkandhla, D.; Hoppe, H. C.; Khanye, S. D.; Kriel, F. H.; Coates, J.; Kaye, P. T. Application of the Morita-Baylis-Hillman Reaction in the Synthesis of 3-[(N-cycloalkylbenzamido)methyl]-2-quinolones as Potential HIV-1 Integrase Inhibitors. Bioorg. Chem. 2017, 75,310-316. DOI: 10.1016/j.bioorg.2017.09.015.
  • Shi, M.; Jiang, J. K.; Cui, S. C. Titanium(IV) Chloride and Oxy-Compounds Promoted Baylis-Hillman Reaction. Tetrahedron 2001, 57,7343-7347. DOI: 10.1016/S0040-4020(01)00710-4.
  • Yadav, V. K.; Babu, K. G. Acetyl Chloride-Ethanol Brings about a Remarkably Efficient Conversion of Allyl Acetates into Allyl Chlorides. Tetrahedron 2003, 59,9111-9116. DOI: 10.1016/j.tet.2003.09.063.
  • Idahosa, K. C.; Lee, Y.-C.; Nyoni, D.; Kaye, P. T.; Caira, M. R. Baylis-Hillman-derived N,N′-Disubstituted Piperazines: structural and Preliminary Computational Studies. Tetrahedron Lett. 2011, 52,2972-2976. DOI: 10.1016/j.tetlet.2011.03.133.
  • Liu, Y.; Zheng, H.; Xu, D.; Xu, Z.; Zhang, Y. An Efficient and Stereoselective Synthesis of (Z)-Allyl Chlorides from Baylis-HILLMAN Adducts Using Vilsmeier-HAACK Reagent. Org. Prep. Proced. Int. Briefs 2007, 39,190-195. DOI: 10.1080/00304940709356011.
  • Claridge, T. D. W. In High-Resolution NMR Techniques in Organic Chemistry, 1st ed.; Elsevier: Oxford, 1999; p141-142.
  • Baraniak, D.; Kacprzak, K.; Celewicz, L. Synthesis of 3'-azido-3'-deoxythymidine (AZT)-Cinchona Alkaloid Conjugates via Click Chemistry: Toward Novel Fluorescent Markers and Cytostatic Agents. Bioorg. Med. Chem. Lett. 2011, 21,723-726. DOI: 10.1016/j.bmcl.2010.11.127.
  • Pedretti, A.; Villa, L.; Vistoli, G. VEGA-an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming. J. Comput. Aided Mol. Des. 2004, 18,167. DOI: 10.1023/B:JCAM.0000035186.90683.f2.
  • Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, J. A.; Jr. Vreven, T.; Kudin, K. N.; Burant, J. C. Gaussian 03, Revision C.02; Gaussian, Inc., Wallingford CT, 2004.
  • Goldgur, Y.; Craigie, R.; Cohen, G. H.; Fujiwara, T.; Yoshinaga, T.; Fujishita, T.; Sugimoto, H.; Endo, T.; Murai, H.; Davies, D. R. Structure of the HIV-1 Integrase Catalytic Domain Complexed with an Inhibitor: a Platform for Antiviral Drug design. Proc. Natl. Acad. Sci. USA. 1999, 96,13040-13043. DOI: 10.1073/pnas.96.23.13040.
  • Lindberg, J.; Sigurdsson, S.; Lowgren, S.; Andersson, H. O.; Sahlberg, C.; Noreen, R.; Fridborg, K.; Zhang, H.; Unge, T. Structural Basis for the Inhibitory Efficacy of Efavirenz (DMP-266), MSC194 and PNU142721 towards the HIV-1 RT K103N Mutant. Eur. J. Biochem. 2002, 269,1670-1677. DOI: 10.1046/j.1432-1327.2002.02811.x.
  • Morris, G. M.; Goodsell, D. S.; Halliday, R. S.; Huey, R.; Hart, W. E.; Belew, R. K.; Olson, A. J. Automated Docking Using a Lamarckian Genetic Algorithm and an Empirical Binding Free Energy Function. J. Comput. Chem. 1998, 19,1639-1662. DOI: 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B.
  • Huey, R.; Morris, G. M.; Olson, A. J.; Goodsell, D. S. A Semiempirical Free Energy Force Field with Charge-based Desolvation. J. Comput. Chem. 2007, 28,1145-1152. DOI: 10.1002/jcc.20634.
  • Serrao, E.; Odde, S.; Ramkumar, K.; Neamati, N. Raltegravir, Elvitegravir, and Metoogravir: The Birth of “me-too”; HIV-1 Integrase Inhibitors. Retrovirology 2009, 6,25 DOI: 10.1186/1742-4690-6-25.
  • Discovery Visual Studio, Release 3.1, San Diego: Accelrys Software Inc., 2011.
  • Shi, M.; Jiang, J.-K.; Cui, S.-C. Amine and Titanium (IV) Chloride, Boron (III) Chloride or Zirconium (IV) Chloride-Promoted Baylis-Hillman Reactions. Molecules 2001, 6,852-868. DOI: 10.3390/61100852.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.